Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Vee Revithi
Senior Consultant to Pharmaceutical Regulatory Authorities on GMP, GDP - Vee Revithi
Professional Bio
Vee (Vasiliki) REVITHI is a Chemist/PhD in Biochemistry, and has worked for 36 years in EOF, the Medicines Authority of Greece. She has been a Head of Division for more than 15 years, 10 of them as Head of the GMDP Inspectorate of the Agency.
Vee led the implementation of a Quality System according to EU, PIC/S and ISO 17020 requirements in the Greek GMDP Inspectorate, the relevant Inspections methodology and the accession of EOF to PIC/S in 2002. She has been involved in the preparation of many regulations regarding medicines and medical devices, in a national and EU level.
She has participated for more than 25 years in EU meetings in Brussels and in the EMA in London.
Vee represented EOF/Greece in the PIC/S Committee (2002 to 2013) and has been a member of its Executive Bureau, more specifically she has been the Chair of Compliance Group (monitoring new applications at PIC/S). She was involved in several Inspectorates’ PIC/S and EU assessment Teams (US FDA, Romania, Austria, Cyprus, Iran, Uganda, Armenia, UNICEF) and was involved at the EU-Japan MRA in 2002-2003.
She performed GMP inspections in cooperation with EDQM and WHO Prequalification Program in India and China and participated in missions of the “Assistance to CFDA” project by WHO/Global Fund (2010 - 2013).
She worked for Roche, Switzerland (June 2013 to May 2018) in External Relations Europe, taking part in several International Conferences (ISPE, PDA etc)
Due to her long experience in PIC/S and EU regulations on GMDP, she has been providing consultancy to Authorities for their accession to PIC/S, eg. Armenia, Turkey, Jordan. She has been cooperating with the Gates Foundation Project for Technical Assistance to CFDI China for their preparation towards accession to PIC/S.